Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) EBIT Margin (2022 - 2024)

Historic EBIT Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 53194.67%.

  • Solid Biosciences' EBIT Margin changed N/A to 53194.67% in Q4 2024 from the same period last year, while for Dec 2024 it was 38155.29%, marking a year-over-year decrease of 480033800.0%. This contributed to the annual value of 38155.29% for FY2024, which is N/A changed from last year.
  • Solid Biosciences' EBIT Margin amounted to 53194.67% in Q4 2024.
  • Over the past 5 years, Solid Biosciences' EBIT Margin peaked at 53194.67% during Q4 2024, and registered a low of 411.44% during Q2 2022.
  • Its 3-year average for EBIT Margin is 30335.37%, with a median of 29926.53% in 2024.
  • Data for Solid Biosciences' EBIT Margin shows a peak YoY increase of 18047200bps (in 2024) and a maximum YoY decrease of 18047200bps (in 2024) over the last 5 years.
  • Solid Biosciences' EBIT Margin (Quarter) stood at 411.44% in 2022, then surged by 6534bps to 26471.07% in 2023, then soared by 101bps to 53194.67% in 2024.
  • Its last three reported values are 53194.67% in Q4 2024, 42904.88% for Q3 2024, and 31577.27% during Q2 2024.